Received Feb 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | IM |
There was no adverse event, but there should have been an 8 week wait time between dose 2 and dose 3. Patient reacted well to vaccination.
N/A
N/A
N/A
No known allergies
N/A